Cargando…
The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial
BACKGROUND AND AIM: To determine the efficacy of the synergistic use of High Power Laser Therapy (HPLT) with glucosamine sulfate (GS) in knee osteoarthritis. METHODS: This 2-arm randomized controlled trial (RCT) enrolled 90 subjects (M=53, F=37, y= 55±11.2) and randomly allocated using a stratified...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343723/ https://www.ncbi.nlm.nih.gov/pubmed/34212917 http://dx.doi.org/10.23750/abm.v92i3.10952 |
_version_ | 1783734344280440832 |
---|---|
author | Ammendolia, Antonio Marotta, Nicola Marinaro, Cinzia Demeco, Andrea Mondardini, Paolo Costantino, Cosimo |
author_facet | Ammendolia, Antonio Marotta, Nicola Marinaro, Cinzia Demeco, Andrea Mondardini, Paolo Costantino, Cosimo |
author_sort | Ammendolia, Antonio |
collection | PubMed |
description | BACKGROUND AND AIM: To determine the efficacy of the synergistic use of High Power Laser Therapy (HPLT) with glucosamine sulfate (GS) in knee osteoarthritis. METHODS: This 2-arm randomized controlled trial (RCT) enrolled 90 subjects (M=53, F=37, y= 55±11.2) and randomly allocated using a stratified sampling method in experimental group (A) with HPLT+GS 1500mg (GS - Dona®, Rottapharm, Monza, Italy) (n=45) or in a control group (B) with HPLT + placebo (n=45). RESULTS: VAS score in Activities of day Living (ADL), Standardized stair climb test (SSCT), Zohlen’s sign (RASPING) and Rabot test were used, to evaluate patients at the beginning of the study (T0), at 2 months (T1) and at 6 months (T2). In the mean scores for VAS in ADL, SSCT, RABOT and RASPING at T1, no significant differences were found between the experimental and the control group with paired T and ANOVA test. But significant differences between groups (p<0.05) in all outcomes were observed at 6 months (T2). CONCLUSIONS: HPLT is useful in treating knee osteoarthritis, but when combined with Glucosamine Sulfate, thanks to the synergy of two interventions, can achieve a long-term effect up to 6 months after treatment. (www.actabiomedica.it) |
format | Online Article Text |
id | pubmed-8343723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-83437232021-08-23 The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial Ammendolia, Antonio Marotta, Nicola Marinaro, Cinzia Demeco, Andrea Mondardini, Paolo Costantino, Cosimo Acta Biomed Original Article BACKGROUND AND AIM: To determine the efficacy of the synergistic use of High Power Laser Therapy (HPLT) with glucosamine sulfate (GS) in knee osteoarthritis. METHODS: This 2-arm randomized controlled trial (RCT) enrolled 90 subjects (M=53, F=37, y= 55±11.2) and randomly allocated using a stratified sampling method in experimental group (A) with HPLT+GS 1500mg (GS - Dona®, Rottapharm, Monza, Italy) (n=45) or in a control group (B) with HPLT + placebo (n=45). RESULTS: VAS score in Activities of day Living (ADL), Standardized stair climb test (SSCT), Zohlen’s sign (RASPING) and Rabot test were used, to evaluate patients at the beginning of the study (T0), at 2 months (T1) and at 6 months (T2). In the mean scores for VAS in ADL, SSCT, RABOT and RASPING at T1, no significant differences were found between the experimental and the control group with paired T and ANOVA test. But significant differences between groups (p<0.05) in all outcomes were observed at 6 months (T2). CONCLUSIONS: HPLT is useful in treating knee osteoarthritis, but when combined with Glucosamine Sulfate, thanks to the synergy of two interventions, can achieve a long-term effect up to 6 months after treatment. (www.actabiomedica.it) Mattioli 1885 2021 2021-07-01 /pmc/articles/PMC8343723/ /pubmed/34212917 http://dx.doi.org/10.23750/abm.v92i3.10952 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Article Ammendolia, Antonio Marotta, Nicola Marinaro, Cinzia Demeco, Andrea Mondardini, Paolo Costantino, Cosimo The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial |
title | The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial |
title_full | The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial |
title_fullStr | The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial |
title_full_unstemmed | The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial |
title_short | The synergic use of the High Power Laser Therapy and Glucosamine sulfate in Knee osteoarthritis: A Randomized Controlled Trial |
title_sort | synergic use of the high power laser therapy and glucosamine sulfate in knee osteoarthritis: a randomized controlled trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343723/ https://www.ncbi.nlm.nih.gov/pubmed/34212917 http://dx.doi.org/10.23750/abm.v92i3.10952 |
work_keys_str_mv | AT ammendoliaantonio thesynergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT marottanicola thesynergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT marinarocinzia thesynergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT demecoandrea thesynergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT mondardinipaolo thesynergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT costantinocosimo thesynergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT ammendoliaantonio synergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT marottanicola synergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT marinarocinzia synergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT demecoandrea synergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT mondardinipaolo synergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial AT costantinocosimo synergicuseofthehighpowerlasertherapyandglucosaminesulfateinkneeosteoarthritisarandomizedcontrolledtrial |